[From AIDSmap, July 11, 2018] “Research is urgently needed to provide clear recommendations on breastfeeding to mothers with HIV who have an undetectable viral load on antiretroviral treatment, a group of researchers say in the journal The Lancet HIV.” For more, click here.
[From Infectious Disease Advisor, July 10, 2018] “There is a substantial prevalence of vitamin D deficiency (<25 nmol/L) worldwide, with estimates of 5% to 15% in high-income countries; rates of vitamin D insufficiency (<75 nmol/L) range from 50% to 75%.1 In addition to its direct effects on bone pathologies,2 increasing evidence links vitamin D deficiency
Influence of Vitamin D in HIV Infection Read More »
[From Healio, July 6, 2018] “A 28-year-old man in Thailand appeared to have acquired multidrug-resistant HIV while on pre-exposure prophlyaxis, or PrEP, researchers reported. It is one of the few cases of PrEP failure with emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) and the first known reported case in a developing country, according to Donn J. Colby, MD,
Researchers identify first known case of PrEP failure in developing country Read More »
[From National AIDS Trust, July 6, 2018] “In 2015, an HIV outbreak was detected amongst people who inject drugs (PWIDs) in Glasgow. Three years on the outbreak has still not been controlled, and over 100 PWIDs in Scotland have been diagnosed with HIV. Those diagnosed have complex needs and experience severe social exclusion, with 40%
GLASGOW’S MAJOR HIV OUTBREAK AMONGST PEOPLE WHO INJECT DRUGS SHOWS NO SIGN OF SLOWING Read More »
[From The Body, July 3, 2018] “Public health officials are expanding efforts to get the HIV prevention pill into the hands of those at risk, in a nationwide effort to curb infections. But the officials are hitting roadblocks — the drug’s price tag, which has surged in recent years, and changes in insurance coverage that
Out-Of-Pocket Costs Put HIV Prevention Drug Out of Reach for Many at Risk Read More »
